Algert Global LLC Enzo Biochem Inc Transaction History

Algert Global LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.17 - $4.09 $43,467 - $56,082	-13,712 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.01 - $3.77 $41,273 - $51,694	13,712 New	13,712 $49,000
Q1 2019 May 01, 2019	SELL	$2.54 - $4.02 $147,754 - $233,847	-58,171 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$2.46 - $4.2 $696,148 - $1.19 Million	-282,987 Reduced 82.95%	58,171 $162,000
Q3 2018 Nov 14, 2018	BUY	$3.81 - $5.53 $328,185 - $476,343	86,138 Added 33.78%	341,158 $1.41 Million
Q2 2018 Aug 02, 2018	BUY	$5.06 - $6.78 $206,544 - $276,752	40,819 Added 19.06%	255,020 $1.32 Million
Q1 2018 May 03, 2018	BUY	$5.43 - $8.36 $922,220 - $1.42 Million	169,838 Added 382.84%	214,201 $1.17 Million
Q4 2017 Feb 01, 2018	BUY	$8.15 - $10.55 $361,558 - $468,029	44,363	44,363 $362,000

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $49.2M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.